Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.47 |
| ▸ | RXRA | P19793 | 2/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.45 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7920280 | 0.89 | PTGS2 (0.58) | PTGS2PTGS1PDPK1ABCB11ALDH1A1 | |
| SCHEMBL8689327 | 0.85 | PTGS2 (0.57) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL8689608 | 0.84 | PTGS2 (0.49) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8692194 | 0.83 | PTGS2 (0.50) | PTGS2PTGS1ABCB11ALDH1A1 | |
| SCHEMBL8639264 | 0.82 | PTGS2 (0.69) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL8639247 | 0.80 | PTGS2 (0.70) | PTGS2PTGS1PDPK1ABCB11 | |
| SCHEMBL8688677 | 0.79 | PTGS2 (0.56) | PTGS2PTGS1RXRANR1H2NR1H3 | |
| SCHEMBL8694131 | 0.79 | PTGS2 (0.71) | PTGS2PTGS1PDPK1 | |
| SCHEMBL8689089 | 0.78 | PTGS2 (0.56) | PTGS2PTGS1PDPK1 | |
| SCHEMBL8691904 | 0.78 | PTGS2 (0.49) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998016227-A9 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA | — | 1998-07-30 | — | — | WO | claimed |
| EP-0941080-A2 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS | G.D. SEARLE & CO. (US) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998022101-A2 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS | G.D. SEARLE & CO. (US) | 1998-05-28 | — | — | WO | disclosed |